STVN - Stevanato Group SpA Long-Term Debt Volume

Graphic logo of Stevanato Group Corp (STVN)

A shortage of premium packaging for GLP-1 drugs is driving capacity expansion at Stevanato Group S.p.A. (STVN). The company's long-term debt chart reflects cost dynamics, where 0.07 shows the current volume of the metric. Strategic alliances with pharma behemoths to create drug delivery systems are fueling growth, while a staff of high-end engineers and automation specialists supports business stability.

STVN Stevanato Group S.p.A. Company Long-Term Debts (07/04/2022 - 10/30/2026)

Stevanato - analytical breakdowns and key metrics (STVN)

- share price and expert price forecast:
Share Price stevanatogroup.com|STVN - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization Stevanato Group|STVN - Enterprise Value
- balance sheet equity data:
Accounting Value per Share Stevanato Group|STVN - Book Capitalization|Market Capitalization to Book Value Ratio stevanatogroup.com|STVN - Aggregate Company Assets
- business debt structure and liquidity details:
Debt to Equity Stevanato Group S.p.A.|STVN - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Stevanato Group Corp|STVN - Company Aggregate Debts|Debts to Net Assets Stevanato Group|STVN - Company Long-Term Debt|Company Short-Term Indebtedness Stevanato Group|Interim Coverage Ratio stevanatogroup.com
- earnings and multiples data:
STVN - Net Income
Summary company analytics:STVN stevanatogroup.com
Manufactured products of Stevanato Group Corp

Scaling production capacities for sterile glass packaging and pharmaceutical equipment requires significant capital expenditures, which is reflected in the borrowing structure of Stevanato Group S.p.A. (STVN). By analyzing the issuer's long-term liabilities on GURU.Markets, an investor assesses the aggregate of multi-year loans to determine the balance between business expansion and the risk of excessive debt leverage, providing a measure of the company's financial stability.

Competitors of Stevanato Group S.p.A. (STVN)

ISRG: Company Long-Term Indebtedness|Danaher - Company Long-Term Debts|Long-Term Debt Volume BD BDX|STE: Company Long-Term Debts|Company Long-Term Liabilities West Pharma Corp|BAX (Baxter International) - Company Long-Term Debts|Company Long-Term Debts masimo.com|Company Long-Term Debt Teleflex (TFX)|Company Long-Term Debt MMSI (Merit Medical Systems, Inc.)|Envista Holdings Corp - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings ICUI|DENTSPLY SIRONA Inc. - Company Long-Term Debts|Long-Term Debt Volume lemaitre.com LMAT|AtriCure (ATRC) - Company Long-Term Debt|Company Long-Term Indebtedness STAA|Company Long-Term Debt Chromadex Corp|ZimVie Corp (ZIMV) - Long-Term Debt Volume|Company Long-Term Liabilities ANGO (AngioDynamics, Inc.)|Amount of Long-Term Liabilities CERS|Company Long-Term Debt Teknova TKNO|Company Long-Term Loans and Borrowings MGRM|STSS: Company Long-Term Liabilities|INFU - Company Long-Term Debts|Utah Medical Products (UTMD) - Company Long-Term Debt|Company Long-Term Liabilities KORU Medical|NYXH (Nyxoah) - Company Long-Term Debts|Long-Term Debt Microbot Medical, Inc. MBOT|Company Long-Term Debt Pro-Dex Corp (PDEX)|Zentek Corp - Company Long-Term Indebtedness|Elutia Inc. - Company Long-Term Liabilities|Amount of Long-Term Liabilities MLSS (milestonescientific.com)|NXGL - Company Long-Term Debt|Long-Term Debt Volume Retractable Technologies RVP|Harvard Bioscience, Inc. (HBIO) - Company Long-Term Debt|FEMY - Long-Term Debt Volume|Company Long-Term Liabilities MHUA|POAI (Predictive Oncology Corp) - Amount of Long-Term Liabilities|Company Long-Term Debts CJMB|ATRI - Long-Term Debt|NeuroMetrix Corp - Company Long-Term Liabilities